If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

13 Nov 2020 11:30

RNS Number : 2853F
Byotrol PLC
13 November 2020
 

 

 

 

 

Byotrol plc

("Byotrol" or the "Group")

 

Result of Annual General Meeting ("AGM")

 

Byotrol plc (AIM: BYOT), the anti-microbial technology company, announces that all resolutions proposed at the AGM held earlier today, as set out in the Notice of Annual General Meeting dated 20 October 2020, were duly passed.

 

The total proxy votes cast prior to the AGM were as follows:

 

Resolution

In favour

Against

Withheld*

Votes

%

Votes

%

Votes

1

78,569,641

99.95

33,300

0.04

5,240,263

2

78,563,620

99.94

39,321

0.05

5,240,263

3

78,563,620

99.94

39,321

0.05

5,240,263

4

83,682,865

99.98

6,771

0.01

153,568

5

83,642,644

99.87

97,278

0.12

103,282

6

83,642,644

99.87

97,278

0.12

103,282

7

83,546,310

99.87

97,278

0.12

199,616

 

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "in favour" or "against" the resolutions.

 

In line with the instructions provided in the Notice and in accordance with the current coronavirus rules implemented by the UK Government, David Traynor and Nic Hellyer, each of whom is a shareholder and/or proxy appointed by one or more shareholders of the Company, formed the quorum for the AGM and were the only persons present throughout. Mr Traynor chaired the AGM. All recommended social distancing precautions were observed by Mr Traynor and Mr Hellyer and the duration of the AGM was minimised in accordance with current Government rules.

 

Directorate Change

 

The Directors also now confirm the formal retirement of Dr Till Medinger from the Board of Byotrol, with thanks for his exceptional service over the past 11 years and sincere best wishes for the future.

 

For further information contact:

 

Byotrol Plc

David Traynor, Chief Executive

+44 (0)1925 742 000

Nic Hellyer, CFO

finnCap Limited (Nominated adviser and broker)

+44 (0)20 7220 0500

Geoff Nash/Kate Bannatyne - Corporate Finance

Richard Chambers - ECM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFLFFLLALVLII
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.